Confused jury prompts Wyeth appeal

Was the jury confused? Apparently so. When a Nevada jury decided in favor of three women who claimed that the company's hormone replacement drugs caused their breast cancer, some jurors thought the $134.5 million awarded included punitive damages. It didn't.

The judge sent the jury back to the drawing board. Compensatory damages: $35 million. After the subsequent punitive phase, the jury tacked on another $99 in punitive damages. No harm, no foul? Not so fast. Wyeth says the confusion strengthens its inevitable appeal.

- see Wyeth's release
- check out the article from CNN Money

Related Articles:
Jury fines Wyeth $134.5M in hormone suit. Report
Jurors deliberate in Prempro trial. Report
Wyeth want end to customized HRT treatments. Report
HRT doesn't protect women from heart disease. Report

Read more on: Wyeth

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.